🔎 Trials Near Me

Beranda › Sarkoma Jaringan Lunak › Ohio

Uji klinis Sarkoma Jaringan Lunak di Ohio

23 studi untuk Sarkoma Jaringan Lunak mencari peserta di lokasi di Ohio.

Kota di Ohio

Teks studi resmi (Bahasa Inggris)

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

  • Ohio State University Comprehensive Cancer Center, Columbus
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06528769

DESTINY-PANTUMOUR04

  • Research Site, Canton
  • Research Site, Maumee
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaFase 1
Usia 12 hingga 85 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT03715933

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

  • Nationwide Children's Hospital, Columbus
Menerima pesertaFase 1/2
Usia 12 hingga 40 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07725380

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Cleveland Clinic - Oncology Department, Cleveland
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06760819

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Summa Health System - Akron Campus, Akron
  • Cleveland Clinic Akron General, Akron
  • Summa Health System - Barberton Campus, Barberton
  • dan 44 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05334069

Actinium Therapy for Late-stage Aggressive Sarcomas

  • Case Western, Cleveland
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07156565

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

  • The James Cancer Hospital and Solove Research Institute, Columbus
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06263231

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

  • Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05210374

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaFase 1/2
Hingga usia 30 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

  • OSU James Hospital, Columbus
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT07377747

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • Ohio State University, Columbus
Menerima pesertaFase 1/2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

  • Aultman Alliance Community Hospital, Alliance
  • Aultman Hospital, Canton
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • The Ohio State University Wexner Medical Center, Columbus
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

  • Ohio State University, Columbus
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Feb 2026 · NCT02677961

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Menerima pesertaFase 1/2
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05734066

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

  • Ohio State University Comprehensive Cancer Center, Columbus
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Feb 2026 · NCT06500065

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Cleveland Clinic, Cleveland
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT06943521

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaFase 1/2
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT06298916

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Nationwide Children's Hospital, Columbus
Menerima pesertaFase 2
18 Months – 40 Years · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT05135975

REtroperitoneal SArcoma Registry: an International Prospective Initiative

  • The Ohio State University, Columbus
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Feb 2019 · NCT03838718

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.